10x Genomics, Inc. provided revenue guidance for full year 2022. For the period, the company expects revenue guidance of $500 million to $520 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.4 USD | +1.29% | -2.42% | -59.98% |
05-29 | 10x Genomics, Inc. Launches 5,000-Plex Gene Panel for Xenium | CI |
05-15 | Transcript : 10x Genomics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 04:20 PM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.98% | 2.65B | |
-6.16% | 11.98B | |
-2.83% | 8.21B | |
+7.95% | 5.81B | |
+29.77% | 5.53B | |
-9.12% | 4.1B | |
+9.11% | 2.61B | |
+17.24% | 2.05B | |
-7.99% | 1.79B | |
+0.97% | 1.57B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- 10X Genomics, Inc. Provides Revenue Guidance for Full Year 2022